Skip to main content
Livermore
Livermore
ZHEN

UBS Group AG

SEC CIK
0001610520
Latest filing
Aug 13, 2026

ALXO holding history

Alx Oncology Holdings Inc in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ALXO overviewAll 13F holders of ALXOFull Q2 2026 holdings

Shares (Q2 2026)
462,943
Value
$958.3K
% of portfolio
<0.1%
Quarters held
20
Since Q1 2021
Holdings of ALXO by UBS Group AG, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026462,943$958.3K<0.1%−451,811−49.4%ReducedHolders
Q1 2026914,754$1.83M<0.1%+48,763+5.6%AddedHolders
Q4 2025865,991$978.6K<0.1%+693,421+401.8%AddedHolders
Q3 2025172,570$315.8K<0.1%−116,115−40.2%ReducedHolders
Q2 2025288,685$119.8K<0.1%+32,192+12.6%AddedHolders
Q1 2025256,493$159.8K<0.1%−151,563−37.1%ReducedHolders
Q4 2024408,056$681.5K<0.1%+378,816+1,295.5%AddedHolders
Q3 202429,240$53.2K<0.1%+13,787+89.2%AddedHolders
Q2 202415,453$93.2K<0.1%−13,621−46.8%ReducedHolders
Q1 202429,074$324.2K<0.1%−1,914−6.2%ReducedHolders
Q4 202330,988$461.4K<0.1%+19,794+176.8%AddedHolders
Q3 202311,194$53.7K<0.1%−1,168−9.4%ReducedHolders
Q2 202312,362$92.8K<0.1%+2,319+23.1%AddedHolders
Q1 202310,043$45.4K<0.1%+2,801+38.7%AddedHolders
Q4 20227,242$81.6K<0.1%+7,242NewHolders
Q2 20220$00.0%−86,072−100.0%Sold outHolders
Q1 202286,072$1.46M<0.1%−7,726−8.2%ReducedHolders
Q4 202193,798$2.02M<0.1%+86,532+1,190.9%AddedHolders
Q3 20217,266$537.0K<0.1%+2,528+53.4%AddedHolders
Q2 20214,738$259.0K<0.1%−14,210−75.0%ReducedHolders
Q1 202118,948$1.40M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.